🧴 Paid Scleroderma Clinical Trials
Browse recruiting scleroderma clinical trials across the United States. Find eligibility information, locations and research opportunities near you.
Browse recruiting scleroderma clinical trials across the United States. Find eligibility information, locations and research opportunities near you.
Showing live studies from ClinicalTrials.gov. Data refreshes daily.
Disclaimer: This content is for educational purposes and is not medical advice. Always consult a qualified healthcare provider for medical guidance.
Scleroderma is a chronic autoimmune disease causing hardening and tightening of the skin and connective tissues. Clinical trials investigate immunosuppressive therapies, anti-fibrotic agents, and treatments for organ-specific complications like pulmonary fibrosis.
Hardening and thickening of skin, Raynaud's phenomenon (fingers turning white/blue in cold), heartburn, joint pain, shortness of breath, calcium deposits in skin, telangiectasias
Female gender, age (30-50), family history, certain ethnic backgrounds (African American, Native American), environmental exposures (silica dust), certain medications
Treatment includes immunosuppressants (methotrexate, mycophenolate), vasodilators for Raynaud's, proton pump inhibitors for reflux, and medications for pulmonary hypertension. Clinical trials explore tyrosine kinase inhibitors (nintedanib), endothelin receptor antagonists, and autologous stem cell transplantation.
Scleroderma clinical trials advance treatment options for this rare disease with limited therapeutic options and significant organ involvement.